Valion Bio, Inc.
VBIO
$2.44
-$0.06-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -267.84% | -312.92% | -92.89% | -81.41% | -52.53% |
| Total Depreciation and Amortization | 60,800.00% | 18,000.00% | -98.90% | -100.00% | -96.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.82% | 131.36% | -35.27% | 672.00% | 220.97% |
| Change in Net Operating Assets | 512.50% | -60.72% | 111.28% | 140.38% | 16.52% |
| Cash from Operations | -189.05% | -463.67% | -67.55% | -41.86% | -41.96% |
| Capital Expenditure | -1,800.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -185.00% | 98.67% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.38% | -- | -100.00% | 2,760.00% | -41.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -58.80% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 39.69% | -62.96% | -480.95% | 180.36% | -314.75% |
| Cash from Financing | -90.22% | -153.66% | 887.35% | 4,504.12% | -28.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,091.65% | -279.74% | 5,017.11% | 250.66% | -74.57% |